Neil S. Horowitz
Brigham and Women's Hospital(US)Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber Brigham Cancer Center(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Gestational Trophoblastic Disease Studies, Prenatal Screening and Diagnostics, Endometrial and Cervical Cancer Treatments, Intraperitoneal and Appendiceal Malignancies
Most-Cited Works
- → Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids(2018)448 cited
- → Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy(2015)369 cited
- → Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer(2009)301 cited
- → Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182(2015)250 cited
- → Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer(2019)219 cited
- → Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer(2020)